Establishment and characterization of two new cell lines derived from human metastatic breast carcinomas

Breast Cancer Research and Treatment

Volumn 43, Issue 2, 1997, Pages 141-151

  Zoli, Wainer ^a   Roncuzzi, Laura ^b,c,d   Zini, Nicoletta ^e   Lenzi, Laura ^b   Gruppioni, Rita ^f   Barzanti, Fabio ^g   Sensi, Alberto ^f   Amadori, Dino ^a   Gasperi Campani, Anna ^b,h  

^a MORGAGNI PIERANTONI HOSPITAL   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d IST Biotechnology Satellite Unit   (Italy)

^e CNR   (Italy)

^f S ANNA HOSPITAL   (Italy)

^g ISTITUTO ONCOLOGICO ROMAGNOLO   (Italy)

^h Department of Experimental Pathology ^*  (Italy)

Author keywords

Chemosensitivity pattern; Cytogenetics; Hormone receptors; Human breast cancer cell line; Oncogenes,; Tumor markers; Ultrastructural analysis

Indexed keywords

CA 15-3 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTOKERATIN; EPIRUBICIN; ESTROGEN RECEPTOR; ETOPOSIDE; FLUOROURACIL; METHOTREXATE; MITOXANTRONE; PROGESTERONE RECEPTOR; TUMOR MARKER;

ADULT; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CASE REPORT; CHEMOSENSITIVITY; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KARYOTYPE; METASTASIS; PLEURA EFFUSION; PRIORITY JOURNAL;

ADULT; BREAST NEOPLASMS; CELL DIVISION; DNA, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; KARYOTYPING; MIDDLE AGED; NEOPLASM METASTASIS; PROTO-ONCOGENES; TUMOR CELLS, CULTURED;

EID: 0030902632     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005740813216     Document Type: Article

References (22)

1. Meltzer P, Leibovitz A, Dalton W, Villar H, Kute T, Davis J, Nagle R, Trent J: Establishment of two new cell lines derived from human breast carcinomas with HER-2/neu amplification. Br J Cancer 63: 727-735, 1991
2. Van der Vijver MJ: Molecular genetic changes in human breast cancer. Adv Cancer Res 61: 25-56, 1993
3. Amadori D, Bertoni L, Flamigni A, Savini S, De Giovanni C, Casanova S, De Paola F, Amadori A, Giulotto E, Zoli W: Establishment and characterization of a new cell line from a primary human breast carcinoma. Breast Cancer Res Treat 28: 251-260, 1993
4. Zoli W, Roncuzzi L, Flamigni A, Gruppioni R, Sensi A, Zini N, Amadori D, Gasperi-Campani A: A new cell line from human infiltrating ductal carcinoma of the breast: establishment and characterization. J Cancer Res Clin Oncol 122: 237-242, 1996
5. Negrini M, Castagnoli A, Pavan JW, Sabbioni S, Araujo D, Collarini A, Gualandi F, Rimessi P, Bonfatti A, Giunta C, Sensi A, Stanbridge EJ, Barbanti-Brodano G: Suppression of tumorigenity and anchorage-independent growth of BK virus-transformed mouse cells by human chromosomes 11. Cancer Res 52: 1297-1303, 1992
6. Dutrillaux B, Lejeune J: New techniques in the study of human chromosomes: methods and applications. Adv Hum Genet 5: 119-156, 1975
7. Seabright M: The use of proteolytic enzymes for the mapping of structural rearrangements in the chromosomes of man. Chromosoma 36: 204-210, 1972
8. EORTC Breast Cancer Cooperative Group: Standard for the assessment of estrogen receptors in human breast cancer. Eur J Cancer 9: 379-381, 1973
9. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JC: Current Protocols in Molecular Biology. Wiley and Sons, New York, 1989
10. Southern EM: Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 98: 503-517, 1975
11. Dalla Favera R, Martinotti S, Gallo RC, Erikson J: Translocation and rearrangement of the c-myc oncogene locus in human undifferentiated B-cell lymphomas. Science 219: 963-967, 1983
12. King CR, Kraus MH, Aaronson SA: Amplification of a novel v-erb-B-related gene in a human mammary carcinoma. Science 229: 974-976, 1985
13. Casey G, Smith R, Mc Gillivray D, Peters G, Dickson C: Characterization and chromosome assignment of the human homolog of int-2, a potential proto-oncogene. Mol Cell Biol 6: 502-510, 1986
14. Taira M, Yoshida T, Miyagawa K, Sakamoto H, Terada M, Sugimura T: cDNA sequence of human transforming gene hst and identification of the coding sequence required for transforming activity. Proc Natl Acad Sci USA 84: 2980-2984, 1987
15. Pulciani S, Santos E, Lauver AV, Long LK, Barbacid M: Transforming genes in human tumors. J Cell Biochem 20: 51-61, 1982
16. Tonigawa N, Kern DH, Hikasa Y, Norton DL: Rapid assay for evaluating the chemosensitivity of human tumors in soft-agar culture. Cancer Res 42: 2159-2164, 1982
17. Devilee P, Cornelisse CJ: Somatic genetic changes in human breast cancer. Biochim Biophys Acta 1198: 113-130, 1994
18. Minafra S, Morello V, Glorioso F, La Fiura AM, Tomasino RM, Feo S, McIntosh D, Wolley DE: A new line (8701-BC) from primary ductal infiltrating carcinoma of human breast. Br J Cancer 60: 185-192, 1989
19. Ito I, Yoshimoto M, Iwase T, Watanabe S, Katagiri T, Harada Y, Kasumi F, Yasuda S, Mitomi T, Emi M, Nakamura Y: Association of genetic alterations on chromosome 17 and loss of hormone receptors in breast cancer. Br J Cancer 71: 438-441, 1995
20. Robertson JFR: Oestrogen receptor: a stable phenotype in breast cancer. Br J Cancer 73: 5-12, 1996
21. Pandis N, Jin Y, Gorunova L, Petersson C, Bardi G, Idvall I, Johansson B, Ingvar C, Mandahl N, Mitelman F, Heim S: Chromosome analysis of 96 primary breast carcinomas. Genes Chrom Cancer 12: 173-185, 1995
22. Moll R: Cytokeratins in the histological diagnosis of malignant tumors. Int J Biol Markers 9: 63-69, 1994